MARKET

AMPH

AMPH

Amphastar Pharma
NASDAQ
20.62
-1.08
-4.98%
After Hours: 20.96 +0.34 +1.65% 19:29 07/18 EDT
OPEN
21.92
PREV CLOSE
21.70
HIGH
22.00
LOW
20.43
VOLUME
430.27K
TURNOVER
--
52 WEEK HIGH
53.96
52 WEEK LOW
20.43
MARKET CAP
972.01M
P/E (TTM)
7.48
1D
5D
1M
3M
1Y
5Y
1D
XPH: Healthcare Dashboard For July
Seeking Alpha · 4d ago
Amphastar announces multi-year expansion of California manufacturing operations
TipRanks · 5d ago
Amphastar Pharmaceuticals to Quadruple U.S. Manufacturing Capacity at Rancho Cucamonga Headquarters
Reuters · 5d ago
Weekly Report: what happened at AMPH last week (0707-0711)?
Weekly Report · 6d ago
Amphastar Pharmaceuticals (AMPH) Gets a Hold from Bank of America Securities
TipRanks · 07/11 10:16
Analysts Forecast 12% Gains Ahead For IJS
NASDAQ · 07/07 14:59
Weekly Report: what happened at AMPH last week (0630-0704)?
Weekly Report · 07/07 09:08
Earnings Working Against Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Share Price
Simply Wall St · 07/01 12:04
More
About AMPH
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. The Company manufactures and sells over 25 products, such as BAQSIMI (glucagon) nasal powder 3mg, Primatene MIST, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone and Other Marketed Products, including Cortrosyn (cosyntropin for injection), Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, and others. The Company manufactures and sells two API products, Recombinant Human Insulin (RHI API) and porcine insulin API, for the injectable insulin market.

Webull offers Amphastar Pharmaceuticals Inc stock information, including NASDAQ: AMPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMPH stock methods without spending real money on the virtual paper trading platform.